Drug or chemical induced diabetes mellitus with ophthalmic complications
ICD-10 E09.3 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with ophthalmic complications.
Drug or chemical induced diabetes mellitus is a form of diabetes that arises as a result of the use of certain medications or chemicals that affect insulin secretion or action. This condition can lead to various complications, including ophthalmic issues such as diabetic retinopathy, cataracts, and other vision-related problems. The onset of diabetes in these cases is typically reversible upon discontinuation of the offending agent, but the ophthalmic complications may persist or worsen if not managed appropriately. Patients may present with elevated HbA1c levels, indicating poor glycemic control, and may require insulin management or other antidiabetic medications to stabilize blood glucose levels. Regular ophthalmic examinations are crucial for early detection and management of complications, as timely intervention can prevent significant vision loss.
Detailed medication history, HbA1c levels, and treatment plans.
Patients presenting with new-onset diabetes after starting a new medication.
Ensure clear documentation of the drug responsible for diabetes and any changes in management.
Comprehensive eye examination findings, including any diabetic retinopathy assessments.
Patients with diabetes presenting for routine eye exams or with vision changes.
Document the relationship between diabetes management and ophthalmic outcomes.
Used for follow-up visits for diabetes management.
Document patient's diabetes status, medication changes, and HbA1c levels.
Endocrinologists should ensure comprehensive management plans are documented.
Common drugs include corticosteroids, certain antipsychotics, and some antihypertensive medications. Each can affect insulin sensitivity or secretion, leading to hyperglycemia.
